Corr P B, Helke C J, Gillis R A
Cardiovasc Res. 1978 Aug;12(8):486-92. doi: 10.1093/cvr/12.8.486.
The influence of the vagolytic effect of procainamide on the early ventricular arrhythmias induced by left anterior descending coronary (LAD) occlusion was studied in chloraloseanaesthetised cats. All control animals developed a ventricular arrhythmia (1119 +/- 166 PVCs per hour), with a consistent onset time, duration, and overall mortality due to ventricular fibrillation (ie 20%). In 18 animals pretreated with procainamide (0.5 mg.kg-1.min-1 for 50 min), there was no effect on the ventricular arrhythmia in terms of ectopic frequency (1020 +/- 180 PVCs per hour), time to onset of arrhythmia, duration of arrhythmia, and mortality incidence (ie 16.7%). However, subdividing the data according to whether or not vagal blockade had been produced by procainamide revealed that animals exhibiting complete vagal blockade demonstrated significantly more ectopic beats (1606 +/- 310 PVCs per hour) and 33% developed ventricular fibrillation. Treated animals without complete vagal blockade exhibited an ectopic frequency rate of 620 +/- 98 PVCs per hour and none of the animals developed ventricular fibrillation. The haemodynamic parameters were similar between both procainamide treated subgroups. These results suggest that an important factor in response of the ischaemic heart to the cardiac rhythm effects of procainamide is the degree of vagal blockade induced by this agent.
在水合氯醛麻醉的猫中,研究了普鲁卡因酰胺的抗迷走神经作用对左前降支冠状动脉(LAD)闭塞诱发的早期室性心律失常的影响。所有对照动物均出现室性心律失常(每小时1119±166次室性早搏),其发作时间、持续时间一致,且因心室颤动导致的总体死亡率(即20%)相同。在18只预先用普鲁卡因酰胺(0.5mg·kg-1·min-1,持续50分钟)处理的动物中,就异位频率(每小时1020±180次室性早搏)、心律失常发作时间、心律失常持续时间和死亡率(即16.7%)而言,对室性心律失常没有影响。然而,根据普鲁卡因酰胺是否产生迷走神经阻滞对数据进行细分后发现,表现出完全迷走神经阻滞的动物显示出明显更多的异位搏动(每小时1606±310次室性早搏),且33%发生了心室颤动。未完全迷走神经阻滞的处理动物的异位频率为每小时620±98次室性早搏,且没有动物发生心室颤动。两个普鲁卡因酰胺处理亚组之间的血流动力学参数相似。这些结果表明,缺血性心脏对普鲁卡因酰胺心律影响反应的一个重要因素是该药物诱导的迷走神经阻滞程度。